Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients [Phase 2, Phase 3]
A placebo-controlled study of SPM 962 in patients with Parkinson's disease completed its Phase 2/Phase 3 program. Results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients [Phase 2]
Phase 2 dose-finding study of SPM 962 for advanced Parkinson's disease has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients [Phase 2]
A long-term extension study stemming from late-phase II testing of SPM 962 in advanced Parkinson's disease; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients [Phase 3]
This update presents long-term extension trial results for SPM 962 in advanced Parkinson's disease from a Phase 3 program, focusing on exten…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients [Phase 2, Phase 3]
A long-term extension study of SPM 962 in early Parkinson's disease patients has completed Phase II/III. Results were posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations [Phase 2]
A Phase 2 trial in advanced Parkinson's disease patients with predictable motor fluctuations has completed, with results posted in 2014 by s…
-
FDA approval · 2014-02-27FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Bromocriptine Mesylate from ANI Pharmaceuticals, Inc., resulting in an updated approval for …
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems [Phase 4]
Phase 4 trial evaluating the rivastigmine transdermal patch in Parkinson's disease patients with dementia or memory/thinking problems. Resul…
-
FDA approval · 2014-02-25FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for benztropine mesylate from Hikma Pharmaceuticals USA Inc., indicating an approved change to an ex…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Executive Control Analysis in Patients Suffering From Parkinson Disease and Treated by Deep Brain Stimulation [NA]
A completed clinical trial evaluating executive control in Parkinson's disease patients treated with deep brain stimulation.
-
FDA approval · 2014-02-21FDA Approved: CARBIDOPA — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved a supplemental application for carbidopa tablets from Oceanside Pharmaceuticals.
-
CLINICAL_TRIALS withdrawal · 2014-02-20Clinical Trial Update: Optimizing DBS Electrode Placement and Programming
A clinical trial evaluating DBS electrode placement and programming for Parkinson's disease and essential tremor has been withdrawn.
-
CLINICAL_TRIALS research · 2014-02-17Clinical Trial Update: Working on Asymmetry in Parkinson's Disease [NA]
This update concerns a clinical trial investigating asymmetry in Parkinson's disease. The current status of the trial is listed as unknown.
-
FDA approval · 2014-02-14FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for the carbidopa/levodopa/entacapone product by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain [Phase 3]
A Phase 3 randomized, placebo-controlled trial evaluating OXN PR for pain in Parkinson's disease with severe pain has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease [Phase 1, Phase 2]
This update reports on the completion of Phase 1/Phase 2 clinical trials evaluating pedunculopontine nucleus stimulation as a gait-disorder …
-
CLINICAL_TRIALS research · 2014-02-04Clinical Trial Update: BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease [NA]
This document provides an update on a clinical trial evaluating body awareness training to reduce wearing-off related anxiety in Parkinson's…
-
CLINICAL_TRIALS research · 2014-01-31Clinical Trial Update: Parkinson's Disease Registry
A clinical trial registry update for a Parkinson disease study (NCT02051205) sponsored by Buddhist Tzu Chi General Hospital; the current sta…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Investigating the Pathophysiological Roles of Cortical, Sub-thalamic Nuclear and Pedunculo-pontine Nuclear Oscillation in Movement Termination of Parkinson Disease Patients
This clinical trial update reports a completed study examining neural oscillations in the cortical areas, subthalamic nucleus, and pedunculo…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease [Phase 4]
A Phase 4 trial evaluating sleep efficiency via polysomnography in advanced Parkinson's disease was terminated; results were posted in Janua…
-
FDA approval · 2014-01-16FDA Approved: CARBIDOPA, LEVODOPA, AND ENTACAPONE — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc's supplemental application for the fixed-dose combination of carbidopa, levodopa, and entacapone.
-
FDA approval · 2014-01-16FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for entacapone submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: The Effects of Auditory Cueing on Rhythmic Movement and Cortical Excitability in Patients With Parkinson's Disease [NA]
This document provides an update on a clinical trial evaluating the effect of auditory cueing on rhythmic movement and cortical excitability…
-
CLINICAL_TRIALS trial_result · 2014-01-15Clinical Trial Update: Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial [Phase 3]
A Phase 3 trial comparing subthalamic nucleus deep brain stimulation (STN-DBS) with globus pallidus interna deep brain stimulation (GPi-DBS)…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating rasagiline for symptomatic fatigue in Parkinson's disease has completed; results have been posted.